• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Flexion Therapeutics

edit

lexion Therapeutics advances drug candidates through clinical proof of concept and beyond, in partnership with pharmaceutical and biotechnology companies. By providing expertise and sharing risk, Flexion effectively expands the portfolios of its partners.

Milestones

edit

• 
  Flexion Therapeutics added Neil Bodick as COO.
  Posted 10/19/09 at 5:56pm
• 
  Flexion Therapeutics added Mike Clayman as CEO.
  Posted 10/19/09 at 5:56pm
• 
  Flexion Therapeutics received $42M in Series A funding. (1/29/10)
  Posted 1/29/10 at 9:14pm via finsmes.com
• 
  Flexion Therapeutics received $33M in Series A funding. (10/1/09)
  Posted 10/19/09 at 5:56pm via fiercebiotech.com

Videos

Screenshots

edit

Above: Home Page
Uploaded: 1/20/10

Sources

1. Flexion garners $33M in Series A (fiercebiotech.com) [edit]
2. Flexion Therapeutics Closes $42M Series A Funding and Three in-licensing Deals (finsmes.com) [edit]